Answers are grounded in this paper and cite their sources.
Regional gastrointestinal and accompanying hepatic transcriptional responses to a Pediococcus acidilactici-containing drinking-water formulation remain incompletely characterized. Sixty healthy male Kunming mice received plain water (NW) or a P. acidilactici-containing formulation (NP) for 50 days under standard-chow conditions. Stomach, small-intestinal, cecal, and colonic contents and paired liver tissue were sampled from the same 12 mice, one per cage (six cages per group). Analyses combined 16S sequencing, targeted fatty-acid quantification, untargeted liquid chromatography–mass spectrometry (LC–MS), and hepatic RNA sequencing. Pediococcus relative abundance was higher at all four sites. Community composition differed in three intestinal regions, with dispersion differences in the small intestine and cecum. Cross-site isobutyrate, isovalerate, and valerate concentrations were 46.3%, 60.5%, and 34.8% lower, respectively (all q = 0.0058). Twelve increased LC–MS features were shared across three intestinal sites. Hepatic RNA sequencing identified 209 genes meeting false discovery rate (FDR) and twofold-change thresholds, including increased Insig1 and Insig2 and decreased mitochondrial transcripts. Mean liver-homogenate triglycerides were 23.2% lower, but neither hepatic biochemistry nor hepatic LC–MS yielded FDR-supported differences. These findings characterize regional gastrointestinal and accompanying hepatic transcriptional responses to the formulation and identify shared intestinal chemical features for targeted investigation. Without a carrier-matched control, strain-specific effects cannot be established.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: